Aligos Therapeutics Statistics

Total Valuation

ALGS has a market cap or net worth of $30.01 million. The enterprise value is -$72.46 million.

Market Cap	30.01M
Enterprise Value	-72.46M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, after market close.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

ALGS has 75.02 million shares outstanding. The number of shares has increased by 263.91% in one year.

Shares Outstanding	75.02M
Shares Change (YoY)	+263.91%
Shares Change (QoQ)	+143.00%
Owned by Insiders (%)	20.55%
Owned by Institutions (%)	61.61%
Float	40.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.18
Forward PS	n/a
PB Ratio	0.50
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.25, with a Debt / Equity ratio of 0.18.

Current Ratio	6.25
Quick Ratio	n/a
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.87

Financial Efficiency

Return on equity (ROE) is -144.20% and return on invested capital (ROIC) is -122.73%.

Return on Equity (ROE)	-144.20%
Return on Assets (ROA)	-84.50%
Return on Capital (ROIC)	-122.73%
Revenue Per Employee	$205,851
Profits Per Employee	-$1.49M
Employee Count	67
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

In the past 12 months, ALGS has paid $780,000 in taxes.

Income Tax	780,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.00% in the last 52 weeks. The beta is 2.28, so ALGS's price volatility has been higher than the market average.

Beta (5Y)	2.28
52-Week Price Change	-60.00%
50-Day Moving Average	0.62
200-Day Moving Average	0.73
Relative Strength Index (RSI)	32.76
Average Volume (20 Days)	558,176

Short Selling Information

The latest short interest is 1.85 million, so 2.47% of the outstanding shares have been sold short.

Short Interest	1.85M
Short Previous Month	1.86M
Short % of Shares Out	2.47%
Short % of Float	4.61%
Short Ratio (days to cover)	7.30

Income Statement

In the last 12 months, ALGS had revenue of $13.79 million and -$99.59 million in losses. Loss per share was -$1.04.

Revenue	13.79M
Gross Profit	13.79M
Operating Income	-86.26M
Pretax Income	-98.81M
Net Income	-99.59M
EBITDA	-83.36M
EBIT	-86.26M
Loss Per Share	-$1.04

Full Income Statement

Balance Sheet

The company has $112.96 million in cash and $10.49 million in debt, giving a net cash position of $102.47 million or $1.37 per share.

Cash & Cash Equivalents	112.96M
Total Debt	10.49M
Net Cash	102.47M
Net Cash Per Share	$1.37
Equity (Book Value)	59.80M
Book Value Per Share	0.80
Working Capital	99.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$79.36 million and capital expenditures -$81,000, giving a free cash flow of -$79.44 million.

Operating Cash Flow	-79.36M
Capital Expenditures	-81,000
Free Cash Flow	-79.44M
FCF Per Share	-$0.51

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -625.40% and -722.06%.

Gross Margin	100.00%
Operating Margin	-625.40%
Pretax Margin	-716.41%
Profit Margin	-722.06%
EBITDA Margin	-604.38%
EBIT Margin	-625.40%
FCF Margin	-575.96%

Dividends & Yields

ALGS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-263.91%
Shareholder Yield	-263.91%
Earnings Yield	-331.88%
FCF Yield	-264.73%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	73.45%
EPS Growth Forecast (5Y)	-50.41%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ALGS has an Altman Z-Score of -6.63 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.63
Piotroski F-Score	4